Helicobacter pylori infection and antibiotic resistance — from biology to clinical implications
The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Performance standards for antimicrobial susceptibility testing
Ferraro, M. J. (2001) · Cited by 9,667
Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., Pulcini, C., Kahlmeter, G., Kluytmans, J., Carmeli, Y., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30753-3 · Cited by 6,142
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
J Antimicrob Chemother 1994; 33: 350–351
O'SHAUGHNESSY, E. M., & DAS, S. S. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.2.350 · Cited by 3,746
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
Hooi, J. K. Y., Lai, W. Y., Ng, W. K., Suen, M. M. Y., Underwood, F. E., Tanyingoh, D., Malfertheiner, P., Graham, D. Y., Wong, V. W. S., Wu, J. C. Y., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.04.022 · Cited by 3,375
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Gisbert, J. P., Kuipers, E. J., Axon, A. T., Bazzoli, F., Gasbarrini, A., Atherton, J., Graham, D. Y., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312288 · Cited by 2,946
International Agency for Research on Cancer (IARC)
(2018) · The Grants Register 2018 · doi:10.1007/978-1-349-94186-5_629 · Cited by 2,801
High-throughput droplet digital PCR system for absolute quantitation of DNA copy number
Hindson, B. J., Ness, K. D., Masquelier, D. A., Belgrader, P., Heredia, N. J., Makarewicz, A. J., Bright, I. J., Lucero, M. Y., Hiddessen, A. L., Legler, T. C., et al. (2011) · Analytical Chemistry · doi:10.1021/ac202028g · Cited by 2,792
Kyoto global consensus report on Helicobacter pylori gastritis
Sugano, K., Tack, J., Kuipers, E. J., Graham, D. Y., El-Omar, E. M., Miura, S., Haruma, K., Asaka, M., Uemura, N., & Malfertheiner, P. (2015) · Gut · doi:10.1136/gutjnl-2015-309252 · Cited by 1,876
beta-Lactamases in laboratory and clinical resistance
Livermore, D. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.557 · Cited by 1,779
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection
Chey, W. D., Leontiadis, G. I., Howden, C. W., & Moss, S. F. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.563 · Cited by 1,604
Mechanism of Quinolone Action and Resistance
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014) · Biochemistry · doi:10.1021/bi5000564 · Cited by 1,282
Savoldi, A., Carrara, E., Graham, D. Y., Conti, M., & Tacconelli, E. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.07.007 · Cited by 1,270
Overview of Next‐Generation Sequencing Technologies
Slatko, B. E., Gardner, A. F., & Ausubel, F. M. (2018) · Current Protocols in Molecular Biology · doi:10.1002/cpmb.59 · Cited by 970
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults
Fallone, C. A., Chiba, N., van Zanten, S. V., Fischbach, L., Gisbert, J. P., Hunt, R. H., Jones, N. L., Render, C., Leontiadis, G. I., Moayyedi, P., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.04.006 · Cited by 927
Nomenclature for the description of human sequence variations
den Dunnen, J., & Antonarakis, S. (2001) · Human Genetics · doi:10.1007/s004390100505 · Cited by 896
Towards a genomics-informed, real-time, global pathogen surveillance system
Gardy, J. L., & Loman, N. J. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.88 · Cited by 771
Review article: the global emergence of Helicobacter pylori antibiotic resistance
Thung, I., Aramin, H., Vavinskaya, V., Gupta, S., Park, J. Y., Crowe, S. E., & Valasek, M. A. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13497 · Cited by 743
Burmølle, M., Webb, J. S., Rao, D., Hansen, L. H., Sørensen, S. J., & Kjelleberg, S. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.03022-05 · Cited by 725
Helicobacter pylori Detection and Antimicrobial Susceptibility Testing
Mégraud, F., & Lehours, P. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00033-06 · Cited by 725
The interconnection between biofilm formation and horizontal gene transfer
Madsen, J. S., Burmølle, M., Hansen, L. H., & Sørensen, S. J. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00960.x · Cited by 718
Worldwide H. pylori antibiotic resistance: a systematic review.
Francesco, V. D., Giorgio, F., Hassan, C., Manes, G., Vannella, L., Panella, C., Ierardi, E., & Zullo, A. (2010) · PubMed · Cited by 560
Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii
Li, J., Rayner, C. R., Nation, R. L., Owen, R. J., Spelman, D., Tan, K. E., & Liolios, L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00103-06 · Cited by 548
Factors influencing the eradication of Helicobacter pylori with triple therapy
Graham, D. Y., Lew, G. M., Malaty, H. M., Evans, D. G., Evans, D. J., Klein, P. D., Alpert, L. C., & Genta, R. M. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90095-g · Cited by 545
Malfertheiner, P., Bazzoli, F., Delchier, J.-C., Celiñski, K., Giguère, M., Rivière, M., & Mégraud, F. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60020-2 · Cited by 523
Mechanisms and clinical relevance of bacterial heteroresistance
Andersson, D. I., Nicoloff, H., & Hjort, K. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0218-1 · Cited by 513
Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori
Versalovic, J., Shortridge, D., Kibler, K., Griffy, M. V., Beyer, J., Flamm, R. K., Tanaka, S. K., Graham, D. Y., & Go, M. F. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.477 · Cited by 501
Using Genomics to Track Global Antimicrobial Resistance
Hendriksen, R. S., Bortolaia, V., Tate, H., Tyson, G. H., Aarestrup, F. M., & McDermott, P. F. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00242 · Cited by 425
Macgregor, C. J., Thomas, C. D., Roy, D. B., Beaumont, M. A., Bell, J. R., Brereton, T., Bridle, J. R., Dytham, C., Fox, R., Gotthard, K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12479-w · Cited by 414
Metronidazole: an update on metabolism, structure–cytotoxicity and resistance mechanisms
Dingsdag, S. A., & Hunter, N. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx351 · Cited by 405
Sensitive detection of Helicobacter pylori by using polymerase chain reaction
Clayton, C. L., Kleanthous, H., Coates, P. J., Morgan, D. D., & Tabaqchali, S. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.1.192-200.1992 · Cited by 376
Complete, closed bacterial genomes from microbiomes using nanopore sequencing
Moss, E. L., Maghini, D. G., & Bhatt, A. S. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0422-6 · Cited by 370
Genome-Based Prediction of Bacterial Antibiotic Resistance
Su, M., Satola, S. W., & Read, T. D. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.01405-18 · Cited by 369
Goldberg, B., Sichtig, H., Geyer, C., Ledeboer, N., & Weinstock, G. M. (2015) · mBio · doi:10.1128/mbio.01888-15 · Cited by 360
Goodwin, A., Kersulyte, D., Sisson, G., Veldhuyzen van Zanten, S. J. O., Berg, D. E., & Hoffman, P. S. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00806.x · Cited by 353
Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence
Graham, D. Y., Lee, Y., & Wu, M. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.05.028 · Cited by 347
Mechanisms of quinolone action and resistance: where do we stand?
Correia, S., Poeta, P., Hébraud, M., Capelo, J. L., & Igrejas, G. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000475 · Cited by 332
Zeng, M., Mao, X.-H., Li, J.-X., Tong, W.-D., Wang, B., Zhang, Y.-J., Guo, G., Zhao, Z.-J., Li, L., Wu, D.-L., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60310-5 · Cited by 305
Antibiotic resistance in : Implications for therapy
GRAHAM, D. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70100-3 · Cited by 300
Guo, Y., Zhang, Y., Gerhard, M., Gao, J.-J., Mejias-Luque, R., Zhang, L., Vieth, M., Ma, J.-L., Bajbouj, M., Suchanek, S., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319696 · Cited by 289
Fallone, C. A., Moss, S. F., & Malfertheiner, P. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.04.011 · Cited by 286
Diagnosis of Helicobacter pylori: What should be the gold standard?
Patel, S. K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i36.12847 · Cited by 284
Suárez, C., & Gudiol, F. (2009) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2008.12.001 · Cited by 283
Erah, P. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/39.1.5 · Cited by 275
Greenberg, E. R., Anderson, G. L., Morgan, D. R., Torres, J., Chey, W. D., Bravo, L. E., Dominguez, R. L., Ferreccio, C., Herrero, R., Lazcano-Ponce, E. C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60825-8 · Cited by 257
Bos, M. P., Tefsen, B., Geurtsen, J., & Tommassen, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402340101 · Cited by 255
Kiga, K., Tan, X.-E., Ibarra-Chávez, R., Watanabe, S., Aiba, Y., Sato’o, Y., Li, F.-Y., Sasahara, T., Cui, B., Kawauchi, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16731-6 · Cited by 244
Resistance of Helicobacter pylori to antibiotics
MÉGRAUD, F. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.11.s1.11.x · Cited by 242
Shah, S. C., Iyer, P. G., & Moss, S. F. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.11.059 · Cited by 239
Macrolide Antibiotics: Binding Site, Mechanism of Action, Resistance
Gaynor, M., & Mankin, A. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452159 · Cited by 235
Rifampin and Rifabutin Drug Interactions: An Update
Finch, C. K., Chrisman, C. R., Baciewicz, A. M., & Self, T. H. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.9.985 · Cited by 233
Helicobacter pylori Biofilm Formation and Its Potential Role in Pathogenesis
Hathroubi, S., Servetas, S. L., Windham, I., Merrell, D. S., & Ottemann, K. M. (2018) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00001-18 · Cited by 227
Dore, M. P., Leandro, G., Realdi, G., Sepulveda, A. R., & Graham, D. Y. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005457226341 · Cited by 223
Clinical Pharmacokinetics of Clarithromycin
Rodvold, K. A. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937050-00003 · Cited by 214
Characterization of Monospecies Biofilm Formation by Helicobacter pylori
Cole, S. P., Harwood, J., Lee, R., She, R., & Guiney, D. G. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.10.3124-3132.2004 · Cited by 213
Chen, L., Xu, W., Lee, A., He, J., Huang, B., Zheng, W., Su, T., Lai, S., Long, Y., Chu, H., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.08.028 · Cited by 205
Mutation discovery in bacterial genomes: metronidazole resistance in Helicobacter pylori
Albert, T. J., Dailidiene, D., Dailide, G., Norton, J. E., Kalia, A., Richmond, T. A., Molla, M., Singh, J., Green, R. D., & Berg, D. E. (2005) · Nature Methods · doi:10.1038/nmeth805 · Cited by 204
Versalovic, J. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.2.283 · Cited by 195
16S rRNA Mutation Associated with Tetracycline Resistance in a Gram-Positive Bacterium
Ross, J. I., Eady, E. A., Cove, J. H., & Cunliffe, W. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1702 · Cited by 194
Schabereiter-Gurtner, C., Hirschl, A. M., Dragosics, B., Hufnagl, P., Puz, S., Kovách, Z., Rotter, M., & Makristathis, A. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.10.4512-4518.2004 · Cited by 193
Rifamycins – Obstacles and opportunities
Aristoff, P. A., Garcia, G. A., Kirchhoff, P. D., & Hollis Showalter, H. D. (2010) · Tuberculosis · doi:10.1016/j.tube.2010.02.001 · Cited by 184
Biofilm Formation by Helicobacter pylori and Its Involvement for Antibiotic Resistance
Yonezawa, H., Osaki, T., & Kamiya, S. (2015) · BioMed Research International · doi:10.1155/2015/914791 · Cited by 181
Rifampin and Rifabutin Resistance Mechanism in Helicobacter pylori
Heep, M., Beck, D., Bayerdörffer, E., & Lehn, N. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1497 · Cited by 180
Ailloud, F., Didelot, X., Woltemate, S., Pfaffinger, G., Overmann, J., Bader, R., Schulz, C., Malfertheiner, P., & Suerbaum, S. (2019) · Nature Communications · doi:10.1038/s41467-019-10050-1 · Cited by 179
Li, B.-Z., Threapleton, D. E., Wang, J.-Y., Xu, J.-M., Yuan, J.-Q., Zhang, C., Li, P., Ye, Q.-L., Guo, B., Mao, C., et al. (2015) · BMJ · doi:10.1136/bmj.h4052 · Cited by 176
Bleyl, D. W. R. (1989) · Food / Nahrung · doi:10.1002/food.19890331009 · Cited by 175
Hu, Y., Zhu, Y., & Lu, N.-H. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00168 · Cited by 175
Mutations in the 16S rRNA Genes of Helicobacter pylori Mediate Resistance to Tetracycline
Trieber, C. A., & Taylor, D. E. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.8.2131-2140.2002 · Cited by 174
Maljkovic Berry, I., Melendrez, M. C., Bishop-Lilly, K. A., Rutvisuttinunt, W., Pollett, S., Talundzic, E., Morton, L., & Jarman, R. G. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz286 · Cited by 173
Standard Mutation Nomenclature in Molecular Diagnostics
Ogino, S., Gulley, M. L., den Dunnen, J. T., & Wilson, R. B. (2007) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2007.060081 · Cited by 172
Efficacy and safety of probiotics in eradicating Helicobacter pylori: A network meta-analysis
Shi, X., Zhang, J., Mo, L., Shi, J., Qin, M., & Huang, X. (2019) · Medicine · doi:10.1097/md.0000000000015180 · Cited by 172
Probiotics in Helicobacter pylori eradication therapy: A systematic review and meta-analysis
Zhang, M.-M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i14.4345 · Cited by 167
Sisson, G., Goodwin, A., Raudonikiene, A., Hughes, N. J., Mukhopadhyay, A. K., Berg, D. E., & Hoffman, P. S. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2116-2123.2002 · Cited by 167
Effect of varying pH on the susceptibility ofCampylobacter pylori to antimicrobial agents
Grayson, M. L., Eliopoulos, G. M., Ferraro, M. J., & Moellering, R. C. (1989) · European Journal of Clinical Microbiology and Infectious Diseases · doi:10.1007/bf01963775 · Cited by 166
Greene, C., Vadlamudi, G., Newton, D. W., Foxman, B., & Xi, C. (2016) · American Journal of Infection Control · doi:10.1016/j.ajic.2015.12.012 · Cited by 165
Smith, S. M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.9912 · Cited by 159
Heteroresistance: a concern of increasing clinical significance?
Falagas, M. E., Makris, G. C., Dimopoulos, G., & Matthaiou, D. K. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01912.x · Cited by 159
van Doorn, L., Glupczynski, Y., Kusters, J. G., Mégraud, F., Midolo, P. D., Maggi-Solcà, N., Queiroz, D. M. M., Nouhan, N., Stet, E., & Quint, W. G. V. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1500-1504.2001 · Cited by 158
Scientific Opinion on nitrofurans and their metabolites in food
(CONTAM), E. P. O. C. I. T. F. C. (2015) · EFSA Journal · doi:10.2903/j.efsa.2015.4140 · Cited by 157
McFarland, L. V., Huang, Y., Wang, L., & Malfertheiner, P. (2016) · United European Gastroenterology Journal · doi:10.1177/2050640615617358 · Cited by 156
Trebesius, K., Panthel, K., Strobel, S., Vogt, K., Faller, G., Kirchner, T., Kist, M., Heesemann, J., & Haas, R. (2000) · Gut · doi:10.1136/gut.46.5.608 · Cited by 153
Heep, M., Rieger, U., Beck, D., & Lehn, N. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.1075-1077.2000 · Cited by 153
Identification of Helicobacter pylori Biofilms in Human Gastric Mucosa
Carron, M. A., Tran, V. R., Sugawa, C., & Coticchia, J. M. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2005.10.019 · Cited by 153
Biofilm formation by Helicobacter pylori
Stark, R. M., Gerwig, G. J., Pitman, R. S., Potts, L. F., Williams, N. A., Greenman, J., Weinzweig, I. P., Hirst, T. R., & Millar, M. R. (1999) · Letters in Applied Microbiology · doi:10.1046/j.1365-2672.1999.00481.x · Cited by 147
Helicobacter pylori and Antibiotic Resistance, A Continuing and Intractable Problem
Hu, Y., Zhang, M., Lü, B., & Dai, J. (2016) · Helicobacter · doi:10.1111/hel.12299 · Cited by 147
Primary Levofloxacin Resistance and gyrA/B Mutations Among Helicobacter pylori in Japan
Miyachi, H., Miki, I., Aoyama, N., Shirasaka, D., Matsumoto, Y. M., Toyoda, M., Mitani, T., Morita, Y., Tamura, T., Kinoshita, S., et al. (2006) · Helicobacter · doi:10.1111/j.1523-5378.2006.00415.x · Cited by 142
Helicobacter pyloritherapy: a paradigm shift
Graham, D. Y., & Dore, M. P. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2016.1178065 · Cited by 141
Genetic Determinants and Prediction of Antibiotic Resistance Phenotypes in Helicobacter pylori
Lauener, F. N., Imkamp, F., Lehours, P., Buissonnière, A., Bénéjat, L., Zbinden, R., Keller, P. M., & Wagner, K. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8010053 · Cited by 139
Jeong, J., Mukhopadhyay, A. K., Dailidiene, D., Wang, Y., Velapatiño, B., Gilman, R. H., Parkinson, A. J., Nair, G. B., Wong, B. C. Y., Lam, S. K., et al. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.18.5082-5090.2000 · Cited by 138
16S rRNA Mutation-Mediated Tetracycline Resistance in Helicobacter pylori
Gerrits, M. M., de Zoete, M. R., Arents, N. L. A., Kuipers, E. J., & Kusters, J. G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2996-3000.2002 · Cited by 137
Kwon, D.-H., El-Zaatari, F. A., Kato, M., Osato, M. S., Reddy, R., Yamaoka, Y., & Graham, D. Y. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2133-2142.2000 · Cited by 136
Self-citationDiagnosis of Helicobacter pylori : What should be the gold standard?
Saurabh, S., Kumar, Patel, et al. (2014) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 136
Chisholm, S., Owen, R. J., Teare, E. L., & Saverymuttu, S. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.4.1217-1220.2001 · Cited by 133
Sisson, G., Jeong, J.-Y., Goodwin, A., Bryden, L., Rossler, N., Lim-Morrison, S., Raudonikiene, A., Berg, D. E., & Hoffman, P. S. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.18.5091-5096.2000 · Cited by 132
Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
Gisbert, J. P., & Calvet (2012) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s25419 · Cited by 128
Infections with Helicobacter pylori and challenges encountered in Africa
Smith, S. I., Fowora, M. A., & Pellicano, R. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i25.3183 · Cited by 126
Hombach, M., Zbinden, R., & Böttger, E. C. (2013) · BMC Microbiology · doi:10.1186/1471-2180-13-225 · Cited by 124
Hoffman, P. S., Goodwin, A., Johnsen, J., Magee, K., & Veldhuyzen van Zanten, S. J. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.16.4822-4829.1996 · Cited by 121
In Vitro Antibacterial Potency and Spectrum of ABT-492, a New Fluoroquinolone
Nilius, A., Shen, L. L., Hensey-Rudloff, D. M., Almer, L. S., Beyer, J., Balli, D., Cai, Y., & Flamm, R. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3260-3269.2003 · Cited by 119
Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori
Hirata, K., Suzuki, H., Nishizawa, T., et al. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06220.x · Cited by 118
High-Level β-Lactam Resistance Associated with Acquired Multidrug Resistance in Helicobacter pylori
Kwon, D. H., Dore, M. P., Kim, J. J., Kato, M., Lee, M., Wu, J., & Graham, D. Y. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2169-2178.2003 · Cited by 115
Amoxycillin tolerance in Helicobacter pylori
Dore, M. P., Osato, M. S., Realdi, G., Mura, I., Graham, D. Y., & Sepulveda, A. R. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.1.47 · Cited by 115
Tang, H., Li, Y., Yong-fang, H., Xie, H., & Zhai, S.-D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062162 · Cited by 114
A change in PBP1 is involved in amoxicillin resistance of clinical isolates of Helicobacter pylori
Okamoto, T., Yoshiyama, H., Nakazawa, T., Park, I.-D., Chang, M.-W., Yanai, H., Okita, K., & Shirai, M. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf140 · Cited by 114
Realdi, G., Dore, M. P., Piana, A. F., Atzei, A., Carta, M., Cugia, L., Manca, A., Are, B. M., Massarelli, G., Mura, I., et al. (1999) · Helicobacter · doi:10.1046/j.1523-5378.1999.99002.x · Cited by 110
Zou, Y., Xing, Q., Liu, X., Song, Y., Song, C., Wu, S., An, Y., Yuan, R., Wang, Y., & Xie, Y. (2020) · Helicobacter · doi:10.1111/hel.12714 · Cited by 110
Tuan, V. P., Narith, D., Tshibangu‐Kabamba, E., Dung, H. D. Q., Viet, P. T., Sokomoth, S., Bình, T. T., Sokhem, S., Tri, T. D., Ngov, S., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060858 · Cited by 109
Self-citationA multiplexed droplet digital PCR assay performs better than qPCR on inhibition prone samples
Sedlak, R. H., Kuypers, J. M., & Jerome, K. R. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.09.004 · Cited by 108
Kim, J. J., Kim, J. G., & Kwon, D. H. (2003) · Helicobacter · doi:10.1046/j.1523-5378.2003.00145.x · Cited by 107
Gerrits, M. M., Schuijffel, D. F., van Zwet, A. A., Kuipers, E. J., Vandenbroucke‐Grauls, C. M. J. E., & Kusters, J. G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2229-2233.2002 · Cited by 103
Dailidiene, D., Bertoli, M. T., Miciuleviciene, J., Mukhopadhyay, A. K., Dailide, G., Pascasio, M. A., Kupcinskas, L., & Berg, D. E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3940-3946.2002 · Cited by 101
Resistance mechanisms ofHelicobacter pyloriand its dual target precise therapy
Gong, Y., & Yuan, Y. (2018) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2017.1418285 · Cited by 99
Ge, X., Cai, Y., Chen, Z., Gao, S., Geng, X., Li, Y., Li, Y., Jia, J., & Sun, Y. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00957-18 · Cited by 96
Gerrits, M. M., Godoy, A. P. O., Kuipers, E. J., Ribeiro, M. L., Stoof, J., Mendonça, S., van Vliet, A. H. M., Pedrazzoli, J., & Kusters, J. G. (2006) · Helicobacter · doi:10.1111/j.1523-5378.2006.00398.x · Cited by 91
Multiple Acid Sensors Control Helicobacter pylori Colonization of the Stomach
Huang, J. Y., Sweeney, E. G., Guillemin, K. J., & Amieva, M. R. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006118 · Cited by 91
A GWAS on Helicobacter pylori strains points to genetic variants associated with gastric cancer risk
Berthenet, E., Yahara, K., Thorell, K., Pascoe, B., Méric, G., Mikhail, J. M., Engstrand, L. G., Enroth, H., Burette, A. C., Mégraud, F., et al. (2018) · BMC Biology · doi:10.1186/s12915-018-0550-3 · Cited by 91
Wu, J. Y., Kim, J. J., Reddy, R., Wang, W. M., Graham, D. Y., & Kwon, D. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.578-583.2005 · Cited by 89
Sun, L., Talarico, S., Yao, L., He, L., Self, S. G., You, Y., Zhang, H., Zhang, Y., Guo, Y., Liu, G., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.00019-18 · Cited by 88
Maeda, S., Yoshida, H., Matsunaga, H., Ogura, K., Kawamata, O., Shiratori, Y., & Omata, M. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.1.210-214.2000 · Cited by 87
Bình, T. T., Shiota, S., Suzuki, R., Matsuda, M., Trang, T. T. H., Kwon, D. H., Iwatani, S., & Yamaoka, Y. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku050 · Cited by 87
Self-citationBiofilm Formation and Antibiotic Resistance Phenotype of Helicobacter pylori Clinical Isolates
Fauzia, K. A., Miftahussurur, M., Syam, A. F., Waskito, L. A., Doohan, D., Rezkitha, Y. A. A., Matsumoto, T., Tuan, V. P., Akada, J. K., Yonezawa, H., et al. (2020) · Toxins · doi:10.3390/toxins12080473 · Cited by 81
Self-citationNovel Method for Rapid Determination of Clarithromycin Sensitivity in Helicobacter pylori
Gibson, J. R., Saunders, N. A., Burke, B., & Owen, R. J. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.11.3746-3748.1999 · Cited by 77
Helicobacter pylori Infection Aggravates Dysbiosis of Gut Microbiome in Children With Gastritis
Yang, L., Zhang, J., Xu, J., Wei, X., Yang, J., Liu, Y., Li, H., Zhao, C., Wang, Y., Zhang, L., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00375 · Cited by 76
Characterization of an In Vitro-Selected Amoxicillin-Resistant Strain of Helicobacter pylori
DeLoney‐Marino, C. R., & Schiller, N. L. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3368-3373.2000 · Cited by 75
Ribeiro, M. L., Gerrits, M. M., Benvengo, Y. H. B., Berning, M., Godoy, A. P. O., Kuipers, E. J., Mendonça, S., van Vliet, A. H. M., Pedrazzoli, J., & Kusters, J. G. (2003) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(03)00277-3 · Cited by 68
Kwon, D. H., Kato, M., El-Zaatari, F. A., Osato, M. S., & Graham, D. Y. (2000) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(00)00235-4 · Cited by 67
Matteo, M. J., Granados, G., Olmos, M. A., Wonaga, A., & Catalano, M. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm504 · Cited by 67
Bình, T. T., Suzuki, R., Trang, T. T. H., Kwon, D. H., & Yamaoka, Y. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04852-14 · Cited by 65
Self-citationWindham, I. H., Servetas, S. L., Whitmire, J. M., Pletzer, D., Hancock, R. E. W., & Merrell, D. S. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.00391-18 · Cited by 65
Tsugawa, H., Suzuki, H., Satoh, K., Hirata, K., Matsuzaki, J., Saito, Y., Suematsu, M., & Hibi∥, T. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3146 · Cited by 62
Glocker, E. O., Berning, M., Gerrits, M. M., Kusters, J. G., & Kist, M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3166-3170.2005 · Cited by 62
Tshibangu‐Kabamba, E., Ngoma-Kisoko, P. D. J., Tuan, V. P., Matsumoto, T., Akada, J. K., Kido, Y., Tshimpi, A. W., Kashala, P. T., Ahuka‐Mundeke, S., Ngoyi, D. M., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8060887 · Cited by 60
Self-citationTsugawa, H., Suzuki, H., Muraoka, H., Ikeda, F., Hirata, K., Matsuzaki, J., Saito, Y., & Hibi∥, T. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.12.034 · Cited by 59
Wu, L., Wang, Z., Sun, G., Peng, L., Lu, Z.-S., Yan, B., Huang, K., & Yang, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-49415-3 · Cited by 58
Debets-Ossenkopp, Y. J., Brinkman, A. B., Kuipers, E. J., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.10.2749 · Cited by 56
Heteroresistance of Helicobacter pylori from the same patient prior to antibiotic treatment
Kao, C., Lee, A.-Y., Huang, A.-H., Song, P.-Y., Yang, Y., Sheu, S., Chang, W.-L., Sheu, B., & Wu, J.-J. (2014) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2014.02.009 · Cited by 53
Iino, C., Shimoyama, T., Chinda, D., Arai, T., Chiba, D., Nakaji, S., & Fukuda, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00712 · Cited by 52
Isolation of a Genetic Locus Associated with Metronidazole Resistance inHelicobacter pylori
Chang, K., Ho, S., Yang, J., & Wang, J. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7050 · Cited by 50
High risk of failing eradication of Helicobacter pylori in patients with diabetes: A meta-analysis
Horikawa, C., Kodama, S., Fujihara, K., Hirasawa, R., Yachi, Y., Suzuki, A., Hanyu, O., Shimano, H., & Sone, H. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.07.009 · Cited by 50
Debets-Ossenkopp, Y. J., Namavar, F., & MacLaren, D. M. (1995) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02116532 · Cited by 45
Helicobacter pylori and Its Antibiotic Heteroresistance: A Neglected Issue in Published Guidelines
Rizvanov, A. A., Haertlé, T., Bogomolnaya, L. M., & Abadi, A. T. B. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01796 · Cited by 45
Kim, S.-Y., Joo, Y. M., Lee, H. S., Chung, I.-S., Yoo, Y., Merrell, D. S., & Cha, J. (2009) · The Journal of Antibiotics · doi:10.1038/ja.2008.6 · Cited by 43
Choi, S. S., Chivers, P. T., & Berg, D. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018236 · Cited by 42
Kocsmár, É., Kocsmár, I., Buzás, G. M., Szirtes, I., Wacha, J., Takáts, A., Hritz, I., Schaff, Z., Rugge, M., Fassan, M., et al. (2019) · Helicobacter · doi:10.1111/hel.12670 · Cited by 41
Macrolide resistance in the normal microbiota after Helicobacter pylori treatment
Jakobsson, H., Wreiber, K., Fall, K., Fjelstad, B., Nyrén, O., & Engstrand, L. (2007) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540701299608 · Cited by 39
Discontinuation Rates of Helicobacter pylori Treatment Regimens: A Meta‐Analysis
Buring, S. M., Winner, L. H., Hatton, R. C., & Doering, P. L. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.4.324.30939 · Cited by 32
Mori, H., Suzuki, H., Matsuzaki, J., Masaoka, T., & Kanai∥, T. (2017) · United European Gastroenterology Journal · doi:10.1177/2050640616688995 · Cited by 31
Metronidazole uptake in Helicobacter pylori
Moore, R. A., Beckthold, B., & Bryan, L. E. (1995) · Canadian Journal of Microbiology · doi:10.1139/m95-102 · Cited by 30
Talarico, S., Korson, A. S., Leverich, C. K., Park, S., Jalikis, F. G., Upton, M. P., Broussard, E. K., & Salama, N. R. (2018) · Helicobacter · doi:10.1111/hel.12472 · Cited by 30
Farzi, N., Behzad, C., Hasani, Z., Alebouyeh, M., Zojaji, H., & Zali, M. R. (2018) · Folia Microbiologica · doi:10.1007/s12223-018-0637-9 · Cited by 28
Yamamoto, Y., Hakki, A., Friedman, H. P., Okubo, S., Shimamura, T., Hoffman, P. S., & Rossignol, J. (1999) · Chemotherapy · doi:10.1159/000007200 · Cited by 26
Next Generation Sequencing in Clinical and Public Health Microbiology
MacCannell, D. (2016) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2016.10.001 · Cited by 26
Ji, C., Liu, J., Li, Y.-Y., Guo, C., Qu, J., Zhang, Y., & Zuo, X. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-037375 · Cited by 25
FecA1, a bacterial iron transporter, determines the survival of Helicobacter pylori in the stomach
Tsugawa, H., Suzuki, H., Matsuzaki, J., Hirata, K., & Hibi∥, T. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.12.011 · Cited by 21
Determinants of antimicrobial effectiveness in H. pylori gastritis
Graham, D. Y. (1994) · Springer eBooks · doi:10.1007/978-94-011-1418-9_51 · Cited by 9
Moghaddam, A. B., Alebouyeh, M., Farzi, N., et al. (2016) · PubMed · Cited by 6
Cited by
Malfertheiner, P., Camargo, M. C., El-Omar, E., Liou, J.-M., Peek, R., Schulz, C., Smith, S. I., & Suerbaum, S. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00431-8 · Cited by 1,191
Updated epidemiology of gastrointestinal cancers in East Asia
Huang, J., Lucero-Prisno, D. E., Zhang, L., Xu, W., Wong, S. H., Ng, S. C., & Wong, M. C. S. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00726-3 · Cited by 269
Antibacterial coatings on orthopedic implants
Chen, X., Zhou, J., Qian, Y., & Zhao, L. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100586 · Cited by 246
“become resistant to antibiotics, resulting in prolonged infections [191, 192].”
BackgroundHelicobacter pylori: A Contemporary Perspective on Pathogenesis, Diagnosis and Treatment Strategies
Ali, A., & AlHussaini, K. I. (2024) · Microorganisms · doi:10.3390/microorganisms12010222 · Cited by 162
Kotilea, K., Iliadis, E., Nguyen, J., Salame, A., Mahler, T., Miendje Deyi, V. Y., & Bontems, P. (2023) · Helicobacter · doi:10.1111/hel.13006 · Cited by 14
Metadata
- Authors
- Tshibangu-Kabamba, E., & Yamaoka, Y.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2021-05-17
- Volume
- 18
- Issue
- 9
- Pages
- 613-629
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W3162032752
- Cited by
- 517
- References
- 156
- FWCI
- 23.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.